BrainStorm Cell Therapeutics
BCLI
#9833
Rank
NZ$1.97 M
Marketcap
$0.37
Share price
3.51%
Change (1 day)
11.58%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Cash on Hand

Cash on Hand as of June 2024 : NZ$5.6 M

According to BrainStorm Cell Therapeutics's latest financial reports the company has NZ$5.6 M in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BrainStorm Cell Therapeutics - Cash on Hand chart (from 2002 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31NZ$4.69 M-85.44%
2021-12-31NZ$32.26 M-44.67%
2020-12-31NZ$58.3 M6812.76%
2019-12-31NZ$0.84 M-91.99%
2018-12-31NZ$10.52 M-3.61%
2017-12-31NZ$10.92 M-24.28%
2016-12-31NZ$14.42 M-38.2%
2015-12-31NZ$23.33 M114.35%
2014-12-31NZ$10.88 M155.26%
2013-12-31NZ$4.26 M-14.42%
2012-12-31NZ$4.98 M102.27%
2011-12-31NZ$2.46 M1935.81%
2010-12-31NZ$0.12 M8626.36%
2009-12-31NZ$0 M-59.99%
2008-12-31NZ$0 M-96.89%
2007-12-31NZ$0.11 M30.68%
2006-12-31NZ$0.08 M
2006-03-31NZ$0.47 M-35.36%
2005-03-31NZ$0.74 M10486.97%
2004-03-31NZ$0 M-61.19%
2003-03-31NZ$0.01 M-77.99%
2002-03-31NZ$0.08 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$4.48 B 79,807.75%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.70 B 30,363.25%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.99 B 35,558.40%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$3.08 B 54,927.39%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.15 B 2,601.73%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA